Re: CYP2D6 Genotype and Tamoxifen Response in Postmenopausal Women With Endocrine-Responsive Breast Cancer: The Breast International Group 1-98 Trial.

Authors :: Stanton Jr., Vincent
Regan, Meredith M.
Bouzyk, Mark
Rae, James M.
Viale, Giuseppe
Leyland-Jones, Brian
Hayes, Daniel F.
Cuzick, Jack
Sestak, Ivana
Dowsett, Mitch
Kelly, Catherine M.
Pritchard, Kathleen I.
Source :: JNCI: Journal of the National Cancer Institute; 8/22/2012, Vol. 104 Issue 16, p1265-1268, 4p
Publication Year :: 2012
Abstract: A letter to the editor is presented in response to the article on the association of CYP2D6 genotype with tamoxifen hormone therapy response in the 2012 issue.

Full Text Access

Tools